Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC in Hypertension
NCT00624052Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of telmisartan, amlodipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Mar 2008; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00624052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624052.